Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 17/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 9/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4113573 | 0.88 | DPP4 (0.65) | DPP4DPP9DPP8 | |
| SCHEMBL4113989 | 0.88 | DPP4 (0.54) | DPP4DPP9DPP8 | |
| SCHEMBL5242208 | 0.83 | DPP4 (0.75) | DPP4DPP9DPP8 | |
| SCHEMBL27723357 | 0.82 | DPP4 (0.56) | DPP4DPP9DPP8 | |
| SCHEMBL5244235 | 0.75 | DPP4 (0.56) | DPP4DPP9DPP8 | |
| SCHEMBL5243223 | 0.75 | DPP4 (0.81) | DPP4DPP9DPP8 | |
| SCHEMBL5242910 | 0.71 | DPP4 (0.50) | DPP4DPP9DPP8 | |
| SCHEMBL4107585 | 0.69 | DPP4 (0.80) | DPP4DPP9DPP8 | |
| SCHEMBL4117724 | 0.69 | DPP4 (0.51) | DPP4DPP9DPP8 | |
| Hydrochloric Acid SCHEMBL5241172 | 0.69 | DPP4 (0.57) | DPP4DPP9DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1851202-A1 | PYRIDYL ACETIC ACID COMPOUNDS | Takeda Pharmaceutical Company Limited (JP) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006090915-A1 | PYRIDYL ACETIC ACID COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-08-31 | — | — | WO | disclosed |